7-Boc-1,7-diaza-spiro[3.5]nonane oxalate is primarily utilized in the field of organic synthesis, particularly in the development of complex molecules. It serves as a key intermediate in the preparation of various pharmaceutical compounds, especially those targeting neurological disorders. The compound’s spirocyclic structure makes it valuable for designing molecules with specific conformational properties, which are crucial for drug-receptor interactions. Additionally, it is employed in the synthesis of peptidomimetics and other bioactive molecules, aiding in the exploration of new therapeutic agents. Its Boc-protected amine group allows for selective deprotection, enabling controlled reactions in multi-step synthetic processes. This chemical is also used in research to study enzyme inhibition and receptor binding mechanisms, contributing to the advancement of medicinal chemistry.